Evidence map›Paper›PMID 25991700›Full record

ReviewILAR journal2015

Livestock models for exploiting the promise of pluripotent stem cells.

R Michael Roberts, Ye Yuan, Nicholas Genovese, Toshihiko Ezashi

Abstract readReview
In one paragraph

Review in ILAR journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Capturing bovine pluripotency.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

R Michael RobertsR. Michael Roberts, DPhil, is a Curators' Professor in the Division of Animal Sciences and Department of Biochemistry at the University of Missouri. Ye Yuan, PhD, is a research scientist; Nicholas Genovese, PhD, is a postdoctoral fellow; and Toshihiko Ezashi, DVM, PhD, is a research associate professor in the Division of Animal Sciences at the University of Missouri.
Ye YuanR. Michael Roberts, DPhil, is a Curators' Professor in the Division of Animal Sciences and Department of Biochemistry at the University of Missouri. Ye Yuan, PhD, is a research scientist; Nicholas Genovese, PhD, is a postdoctoral fellow; and Toshihiko Ezashi, DVM, PhD, is a research associate professor in the Division of Animal Sciences at the University of Missouri.
Nicholas GenoveseR. Michael Roberts, DPhil, is a Curators' Professor in the Division of Animal Sciences and Department of Biochemistry at the University of Missouri. Ye Yuan, PhD, is a research scientist; Nicholas Genovese, PhD, is a postdoctoral fellow; and Toshihiko Ezashi, DVM, PhD, is a research associate professor in the Division of Animal Sciences at the University of Missouri.
Toshihiko EzashiR. Michael Roberts, DPhil, is a Curators' Professor in the Division of Animal Sciences and Department of Biochemistry at the University of Missouri. Ye Yuan, PhD, is a research scientist; Nicholas Genovese, PhD, is a postdoctoral fellow; and Toshihiko Ezashi, DVM, PhD, is a research associate professor in the Division of Animal Sciences at the University of Missouri.
University of Missouri · US

Funding

Induced Pluripotent Stem Cells from Swine: application to genetic modificationR01HD069979 · NICHD · UNIVERSITY OF MISSOURI-COLUMBIA · PI ROBERTS, R. MICHAEL · 2012 to 2016
$1.5M
NICHD NIH HHS R01 HD069979NICHD NIH HHS R01HD069979
6 · The paper itself

Abstract

Livestock species are widely used as biomedical models. Pigs, in particular, are beginning to have a significant role in regenerative medicine for testing the applicability, success, and safety of grafts derived from induced pluripotent stem cells. Animal testing must always be performed before any clinical trials are performed in humans, and pigs may sometimes be the species of choice because of their physiological and anatomical similarities to humans. Induced pluripotent stem cells (iPSC) have been generated with some success from livestock species by a variety of reprogramming procedures, but authenticated embryonic stem cells (ESC) have not. There are now several studies in which porcine iPSC have been tested for their ability to provide functional grafts in pigs. Pigs have also served as recipients for grafts derived from human iPSC. There have also been recent advances in creating pigs with severe combined immunodeficiency (SCID). Like SCID mice, these pigs are expected to be graft tolerant. Additionally, chimeric, partially humanized pigs could be sources of human organs. Another potential application of pluripotent stem cells from livestock is for the purpose of differentiating the cells into skeletal muscle, which, in turn, could be used either to produce cultured meat or to engraft into damaged muscle. None of these technologies has advanced to a stage that they have become mainstream, however. Despite the value of livestock models in regenerative medicine, only a limited number of institutions are able to use these animals.

Indexed as

LivestockAnimalsHumansInduced Pluripotent Stem CellsMiceModels, AnimalRegenerative Medicineanimal modelschimeracloningcultured meatinduced pluripotent stem cells (iPSC)nuclear transferpigregenerative medicinesevere combined immunodeficiency (SCID)

Identifiers

PMID25991700
PMCPMC4542707
OpenAlexW1779198087

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.